Monica Guma, MD
Enriched profileProfessor of Medicine and Chief of the Division of Rheumatology, Autoimmunity and Inflammation, UC San Diego · University of California San Diego
Monica Guma is Professor of Medicine and Chief of the Division of Rheumatology, Autoimmunity and Inflammation, UC San Diego at University of California San Diego. OpenAlex indexes 185 publications with 10,594 citations (h-index 47); ClinicalTrials.gov lists 4 registered studies with this person as an investigator.
Data verified 17 Aug 2026
Overview
Updated 15 Oct 2026
Monica Guma, M.D., PH.D., is Professor of Medicine and Chief of the Division of Rheumatology, Autoimmunity and Inflammation, UC San Diego at University of California San Diego. The public record shows 185 publications with 10,594 citations (h-index 47), centered on Rheumatoid Arthritis Research and Therapies, Immune Cell Function and Interaction, Metabolomics and Mass Spectrometry Studies. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 3 companies, 6 NIH-funded awards (2013–2026).
- Most recent indexed publication: 2026 · The Journal of rheumatology
- Top research focus: Rheumatoid Arthritis Research and Therapies
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 3 companies
Generated from the cited public record · current as of 15 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 14 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 88.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 15 Oct 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Effect of Anti-inflammatory Diet in Systemic Lupus Erythematous
Sponsor: University of California, San Diego
- R-2487 in Patients With Rheumatoid Arthritis
Sponsor: Rise Therapeutics LLC
- Effect of Anti-inflammatory (ITIS) Diet in Knee Osteoarthritis
Sponsor: University of California, San Diego
Industry payments
Updated 15 Oct 2026
3 companies reported payments to CMS in program years 2023–2024. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20241 payment
- Janssen Scientific Affairs, LLCProgram year20242 payments
- UCB, Inc.Program year20241 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
57.2%TNF inhibitor23.5%Enbrel Sureclick31%Humira(Cf) Pen20%Enbrel18%Humira18%Humira Pen14%Part D<11 patientsFolate Analog Metabolic Inhibitor17.6%Methotrexate100%Part D≥14 patients+ 2 more classes in this area
Antiparasitic
20.2%Antimalarial20.2%Hydroxychloroquine Sulfate100%Part D≥11 patientsMetabolism & gastrointestinal
10.9%Corticosteroid7.3%Prednisone100%Part D<11 patientsAminosalicylate3.5%Sulfasalazine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 15 Oct 2026
6 NIH research awards on record, funded 2013–2026 per NIH RePORTER. The latest:
- Obesity-Induced Inflammatory Mediators Predict Lack of Response in Patients with Rheumatoid Arthritis Starting Biological Therapies
University of California, San Diego
FY2026$461,990R01AR083584 - Rheumatic Diseases Research Training Grant
University of California, San Diego
FY2026$296,441T32AR064194 - Obesity-Induced Inflammatory Mediators Predict Lack of Response in Patients with Rheumatoid Arthritis Starting Biological Therapies
University of California, San Diego
FY2025$440,563R01AR083584
Publications
Updated 15 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- A Similar Mutation in the AAUU-Rich Elements of the Mouse TNF Gene Results in a Distinct Ileocolitic Phenotype: A New Strain of TNF-Overexpressing Mice.
Inflammatory bowel diseases
Article2025 - Synovial 5-Lipoxygenase-Derived Oxylipins Define a Lympho-Myeloid-Enriched Synovium.
Arthritis & rheumatology (Hoboken, N.J.)
Article2024
Most-cited works
by citation count (OpenAlex)- 01NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1αArticle1,590 citations2008
- 02Synovial inflammation in osteoarthritis progressionArticle1,024 citations2022
- 03Imprint of human cytomegalovirus infection on the NK cell receptor repertoireArticle859 citations2004
- 04Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblastsArticle444 citations2005
- 05Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritisArticle421 citations2017
Network
Updated 15 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 15 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/monica-guma-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
arthritis.org/liveyes/podcast/new-podcast/microbiome-gut-health-podcast
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →arthritis.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 15 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- M.D.
Autonomous University of Barcelona, Spain
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rheumatology.ucsd.edu ↗ - Ph.D. in Immunology
Pompeu Fabra University, Barcelona, Spain
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rheumatology.ucsd.edu ↗
Editorial & leadership roles
journal and society appointments- Editorial Board / Section Editor
Arthritis Research & Therapy
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →arthritis-research.biomedcentral.com ↗
Secondary affiliations
appointments beyond the home institution- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Media & interviews
press, podcasts and appearances- Guest
"Microbiome, Gut Health & Arthritis" podcast (Episode 60), Arthritis Foundation, discussing diet's impact on disease activity and therapeutic response, released January 19
2021verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →arthritis.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Weinreb, MD
University of California San Diego
Dilip Jeste, MD
University of California San Diego
Mark Ginsberg, MD
University of California San Diego
Lawrence Eichenfield, MD
University of California San Diego
Marc Hochberg, MD
University of Maryland School of Medicine
Michelle Petri, MD
Johns Hopkins University School of Medicine
Dinesh Khanna, MD
University of Michigan
Matthew Liang, MD
Brigham and Women's Hospital